3.1. Saponin Profiles of the Various Asparagus Species Analyzed in This Work
The total saponins-contained crude extract ranged from 710.0 (A. officinalis) to 1258.6 mg/100 g dw (A. acutifolius). These results are in line with those of Shao et al. (1996), who obtained 1.72 g/100 g dw from A. officinalis shoots (gravimetrically determined). Vázquez-Castilla et al. (2013) reported very low amounts in shoots: 10.9–27.3 mg/kg fw of Huétor Asparagus. Concerning A. acutifolius, Hamdi et al. (2021) reported total saponins at 1419 mg/kg dw.
Asparagus saponins are steroidal glycosides. In A. officinalis, and most of the green and white commercial hybrids derived from this specie, the main saponin is protodioscin (C51H84O22), which is a glycoside derivative of the furostanoid type diosgenin (Vázquez-Castilla et al., 2013). To date, about more than 20 saponin aglycones have been identified in the genus Asparagus, however, only sarsasapogenin, asparanin A, protodioscin, yamogenin, and its derivatives have been studied (Pegiou et al., 2020). Then, the richness of compounds detected in this work stands out. A total of 47 saponins have been detected and quantified in the edible parts (shoots) of 5 taxa of wild Asparagus and farmed A. officinalis.
The sum of dioscin and derivatives, i.e., protodioscin, protoneodioscin, pseudoprotodoioscin, pseudoprotoneodioscin, and methyl protodioscin, varied largely along the studied taxa. It reached the following percentages of TS: 27.11 (A. officinalis), 18.96 (A. aphyllus), 5.37 (A. acutifolius), and 0.59 (A. albus), while in A. horridus such compound were undetected. Interestingly, diosgenin, a protodioscin moiety, was not found.
3.3. Antiproliferative Activity of the Saponins Extracts of Asparagus Shoots on HT-29 Cancer Cells
The saponins from Asparagus spp. have long been characterized as having antitumor activity. For instance, the crude saponins extract from the shoots of A. officinalis were cytostatic and cytocidal against the human leukemia HL-60 cells, and inhibited the synthesis of DNA, RNA, and proteins (Shao et al., 1996).
Reports indicated that the cytotoxic activity is characteristic of each Asparagus organ. Overall, the ethanolic extracts of rhizome and leaf are cytotoxic; however, low activity has been described for shoot extracts (Hamdi et al., 2021). The rhizome extracts from several Asparagus species were tested against the HepG2 (liver cancer) cell line. Three Asparagus species, namely A. acutifolius (Hamdi et al., 2021), A. adscendent (Khan et al., 2017), and A. filicinius (Liu et al., 2015) exercised noticeable cytotoxic activity, and this activity has been related to the occurrence of saponins and their genins. However, the rhizome extract of A. albus showed low activity (Hamdi et al., 2017).
Some pure saponins isolated from Asparagus spp. have been tested against cancer cells. For instance, asparanin A, a steroidal saponin, exhibited anticancer activity on endometrial cancer. This saponin inhibited cell proliferation and caused cell morphology alteration and cell cycle arrest in G0/G1 phase, the apoptosis through mitochondrial pathway, generation of ROS, and activation of caspases, besides other mechanisms. In vivo inhibited the tumor cell proliferation and growth, and induced apoptosis (Zhang et al., 2020). Asparanin A also induces cell cycle arrest and triggers apoptosis via a p53-independent manner in HepG2 cells (Liu et al., 2009).
In terms of activity against colorectal cancer cells, the saponins from Asparagus have been typified as inhibitors through cytotoxicity and apoptosis (Bousserouel et al., 2013). For instance, the saponins from edible spears of wild asparagus (triguero Huétor-Tájar, HT, landrace) inhibit AKT, p70S6K, and ERK signaling, and induce apoptosis through G0/G1 cell cycle arrest in human colon cancer HCT-116 cells (Jaramillo et al., 2016). Both the rhizome and leaf from A. acutifolius showed high activity against this cell line, while the leaf extracts from A. officinalis and A. acutifolius species had similar IC50 values (Hamdi et al., 2017). Interestingly, when checking the rhizome extract of A. officinalis against HCT-116 cells, the IC50 value was better than that of the saponins extracted from the corresponding by-products (Wang et al. 2013), and this result was related to a different saponin composition or to the synergistic effects among the various phytochemicals presents in A. acutifolius extracts.
Zhao (2012) reported activity of the saponins-containing crude extract against the colon cancer cell lines SW620 and HCT-116 through induction of cytotoxicity. Jaramillo-Carmona et al. (2018) found that protodioscin induced cytotoxicity in HCT-116, HT-29, and Caco-2 colon cancer cells. Dioscin exercises antitumor activities against several types of tumors, such as lung cancer, gastric cancer, colon cancer, glioblastoma, cervix carcinoma, ovarian cancer, breast cancer, prostate cancer, and leukemia. Its antitumor activity is exercised through intrinsic mitochondrial apoptosis, involving activation of caspase-9 and caspase-3, and induces a reduction in antiapoptotic proteins such as Bcl-2, Bcl-xl, cIAP-1, and Mcl-1 (Yang et al., 2019). Kang et al. (2011) checked the activity of asparanin A against colon cancer HCT-15 cells and found that this compound induced apoptosis and inhibited cells proliferation through cell-cycle arrest in the G0/G1 and G2/M phase.
In this work, after 48 and 72 h of treatment, the MTT assay revealed concentration- and time-dependent inhibitory effects on HT-29 cells for all assayed extracts (Figures 6A and 6B). The antitumor activity was especially intense for the extracts obtained from the stems of A. albus and A. acutifolius. In the case of A. albus, it contains saponins that in descending order are aspaspirostanoside IV, aspafurostanol II, and aspaspirostanoside V. However, considering that these same saponins are found in A. aphyllus, which develops low activity against HT-29 cells, it is difficult to attribute the observed activity to such saponins. This is not the case of A. acutifolius, which contains characteristic saponins, such as aspafurostanol I, asparanin B (shatavarin-IV), and aspachoioside M, which could have exerted the noted action. Interestingly, these two highly active species are the only ones that contain shatavarin IV, especially A. acutifolius. This saponin was previously isolated from A. racemosus roots. The cytotoxicity (in vitro) of shatavarin IV extracts (approximately 5% of shavaratins) and other shatavarins rich fraction was assayed by the MTT test against HT-29 cells, showing significant anticancer activity in both in vitro and in vivo experimental models (Mitra et al., 2012). Therefore, considering the content of shavaratin IV (11.30 in A. acutifolius and 1.49% in A. albus), it is likely that the noted activity was due to this saponin type, at least partially.
Although A. officinalis shows high percentages of dioscin and its derivatives, the activity of its crude extract against HT-29 cells was very week, which induces to consider that this cell line is low sensitive to these saponin types.
The National Cancer Institute (NCI) consider that compounds/extracts/fractions as cytotoxic when the GI50 values are within the 20–30 µg/mL range (Boik, 2001). Based on the MTT results, the saponin extracts checked lack cytotoxicity, while diosgenin was recognized as cytotoxic to the tested cell line. It should be noted that the extracts tested are not completely made up of saponins; therefore, it is quite possible that isolation of pure saponin fractions from these extracts will yield cytotoxic compounds. The GI50 value of diosgenin for the HT-29 cell line obtained in the current work by the MTT assay is consistent with previous studies for such compound on HeLa cancer cell line (e.g., Stefanowicz-Hajduk et al., 2021). On the other hand, according to the threshold proposed by Suffness and Pezzuto (1990), crude extracts showing a GI50 ≤ 100 µg/mL can be selected for further studies, whereas the most promising ones are those with a GI50 <30 µg/mL. Thus, the saponin extract from A. albus shoot, whose GI50 is close to this figure (120 µg/mL), merit further research for its fractionation until pure active compounds are isolated. Then, the mechanisms of action of such compounds against different cancer cell lines would be checked according to different methodologies.
It should be noted that the antiproliferative effects of the extracts may not be due to specific compounds. It is likely that interactions among the various saponins and with other components of the extract could have contributes to the overall reported effects. In this regard, it has been reported the anticancer effects of the deproteinized Asparagus polysaccharide on hepatocellular carcinoma cells. Asparagus polysaccharide exercised effective inhibitor effects on cell growth in vitro and in vivo and exert potent selective cytotoxicity against human hepatocellular carcinoma Hep3B and HepG2 cells. Such polysaccharide develops activity through an apoptosis-associated pathway by modulating the expression of Bax, Bcl-2, and caspase-3, and has been proposed as a potential therapeutic agent (or chemosensitizer) for liver cancer therapy (Xiang et al., 2014).